Discover trends, market shifts, and competitive outlooks for the intravenous solutions industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Intravenous Solutions Market In 2029?

In recent years, the market size for intravenous solutions has shown significant growth. It is projected to increase from $14 billion in 2024 to $15.05 billion in 2025, suggesting a compound annual growth rate (CAGR) of 7.5%. This growth during the historical period is due to factors such as the increase in surgical procedures, the rising incidence of chronic diseases, the expansion of home healthcare services, strict regulations to ensure product safety, a heightened emphasis on patient hydration, and worldwide initiatives for emergency preparedness.

The market size of intravenous solutions is projected to witness robust expansion in the upcoming years, with an estimated valuation of $20.51 billion in 2029 and a compound annual growth rate (CAGR) of 8.0%. Factors contributing to this growth during the forecast period include population and aging growth, an uptick in surgical procedures, a rise in infectious diseases, the evolution of telemedicine and remote patient monitoring, a shift towards preventive healthcare, investments in global health security, and emphasis on patient-centered care. The forecast period will also see significant trends like an escalated demand for parenteral nutrition solutions, growing inclination towards pre-mixed iv solutions, broadening scope of home infusion therapies, the launch of electrolyte-balanced solutions, the introduction of innovative drug additives and adjuncts, as well as the incorporation of intelligent iv systems for monitoring.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13465&type=smp

What are the Fundamental Drivers and Innovations Shaping the Intravenous Solutions Market?

The rise in cancer cases is likely to fuel the expansion of the intravenous solutions market. The unregulated growth of cells, their ability to infiltrate nearby tissues, and metastasize to different body parts define cancer. Commonly, intravenous solutions are deployed in cancer treatments to facilitate chemotherapy drugs and maintain hydration throughout the therapy. For example, in February 2024, the World Health Organization, an intergovernmental organization based in Switzerland, predicted more than 35 million new cancer cases by 2050, marking a 77% surge compared to the approximately 20 million cases estimated in 2022. Thus, the escalating prevalence of cancer is influencing the growth of the intravenous solutions market. Likewise, the rise in surgical procedures is likely to boost the intravenous solutions market. Surgical procedures, which entail treating various diseases and disorders via cuts or other invasive techniques, require intravenous solutions for hydration, electrolyte balance, medication delivery, and emergency interventions. For example, the International Society of Aesthetic Plastic Surgery, a US-based official journal of the same society, reported in September 2023 that nearly 14.9 million surgical and 18.8 million non-surgical procedures were conducted across the globe in 2022, indicating an 11.2% increase in total procedures. Hence, the rise in surgical procedures is driving the intravenous solutions market’s expansion.

How Is the Intravenous Solutions Market Segmented?

The intravenous solutions market covered in this report is segmented –

1) By Product: Total Parenteral Nutrition, Peripheral Parenteral Nutrition

2) By Nutrients: Carbohydrates, Vitamins And Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, Other Nutrients

3) By Application: Basic Intravenous (IV) Solution, Nutritional Intravenous (IV) Solution, Blood Intravenous (IV) Solution, Drug Intravenous (IV) Solution, Irrigation Intravenous (IV) Solution

4) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings

Subsegments:

1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions, Multivitamin Solutions

2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13465&type=smp

Which Regions Are Driving the Next Phase of the Intravenous Solutions Market Growth?

North America was the largest region in the intravenous solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Intravenous Solutions Market?

Leading firms in the intravenous solutions market are concentrating on the creation of novel syringes such as pre-filled and ready-for-use versions to enhance their market standing. These syringes, already loaded with medication, require no manual filling and are ready for immediate utilization, thereby cutting down on preparation time. A case in point is GENIXUS Corp., a healthcare firm based in the US, that in August 2023 released its KinetiXTM Rocuronium Bromide Injection in 5mL and 10mL ready-to-use syringes. These syringes are constructed from a clear and robust polymer material, tackling the potential risks linked to glass syringes. The syringes, being pre-filled and ready-to-use, save time and diminish the chances of medication mishaps. The Rocuronium bromide injection is exclusively for intravenous application and comes with several crucial features such as intuitive labeling, RFID-enabled with KitCheck for state-of-the-art kit and tray management techniques, and a color-coded plunger rod for easy identification.

View the full report here:

https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report

How Is the Intravenous Solutions Market Defined and What Are Its Core Parameters?

Intravenous solutions are sterile liquids administered directly into a patient’s bloodstream, typically for hydration, medication delivery, or nutrient supplementation. They are used in intravenous therapy to restore or maintain normal fluid volume and electrolyte balance when the oral route is impossible.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13465

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model